Basic Information
Basic information for C21orf62-AS1-210-31aa
Peptide Name C21orf62-AS1-210-31aa
Genome Position chr21:32801443-32801535[+]
Species Human
Peptide Sequence MPSRDLKCAQRTWNVLWEQTTGQLIIRQCDW
Peptide Length 31
Unique No (C21orf62-AS1-213-31aa-1)
Grand Average of Hydropathicity -0.6355
Relative Molecular Mass 4317.89
Experimental Evidences no
lncRNA ID/Name ENSG00000205930;C21orf62-AS1
Transcript ID/Name ENST00000661254;C21orf62-AS1-210
Transcript Length 1267
Coding Ability 0.3583
DNA Sequence Corresponding to Peptide ATGCCCTCAAGGGACTTGAAGTGTGCCCAGAGAACTTGGAATGTACTCTGGGAACAAACAACTGGGCAACTAATTATAAGACAATGTGATTGG
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :